Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rojkjaer Lisa
Rigel Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Rojkjaer Lisa
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Schorno Dean L
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Santos David A
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer RODRIGUEZ RAUL R
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Furey Raymond J.
Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.81%),Steven Boyd(9.81%)
Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.13%)
Rigel Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(8.3%),Morgan Stanley Capital Services LLC(8.1%)
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Santos David A
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Schorno Dean L
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer RODRIGUEZ RAUL R
Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(0.1 %),GOLDMAN SACHS & CO. LLC(0.1 %)
Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(5.4%),Soleus Capital, LLC(5.4%), etc.
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Furey Raymond J.
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer RODRIGUEZ RAUL R
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Santos David A
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Schorno Dean L
Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.7%)
Rigel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LAPOINTE ANTHONY GREGG
No Data